In vitro studies on lung cancer cells showed that decrease in phosphorylation level of extracellular signal-regulated kinase (ERK) 1/2 and Akt mediated by FGFR inhibition with AZD4547 or BAY1163877 was hampered by MET activation (16). The gene discussed is MET; the disease is lung carcinoma.